CGM 📈 Cegedim S.A. - Overview
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000053506
CGM: Software, Data, Healthcare, Insurance, Management, Services
Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals in France, other European countries, and internationally. It operates in two segments, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services segment markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This segment also provides solutions for hosting, HR and payroll management outsourcing, electronic data exchange, and data processing services. The Healthcare Professionals division sells management software, databases, and solutions to doctors, allied health professionals, pharmacists, and healthcare facilities. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SA. Web URL: https://www.cegedim.com
Additional Sources for CGM Stock
CGM Stock Overview
| Market Cap in USD | 158m |
| Sector | Healthcare |
| Industry | Health Information Services |
| GiC Sub-Industry | Health Care Technology |
| IPO / Inception |
CGM Stock Ratings
| Growth 5y | -82.7% |
| Fundamental | 30.8% |
| Dividend | 1.21% |
| Rel. Strength Industry | -1130 |
| Analysts | - |
| Fair Price Momentum | 10.60 EUR |
| Fair Price DCF | 125.53 EUR |
CGM Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 45.7% |
CGM Growth Ratios
| Growth Correlation 3m | -28.2% |
| Growth Correlation 12m | -92.9% |
| Growth Correlation 5y | -88.6% |
| CAGR 5y | -14.17% |
| CAGR/Mean DD 5y | -0.42 |
| Sharpe Ratio 12m | -0.91 |
| Alpha | -44.45 |
| Beta | 0.60 |
| Volatility | 38.58% |
| Current Volume | 31.5k |
| Average Volume 20d | 14.3k |
What is the price of CGM stocks?
As of December 22, 2024, the stock is trading at EUR 12.95 with a total of 31,460 shares traded.
Over the past week, the price has changed by -0.37%, over one month by +21.72%, over three months by +7.60% and over the past year by -24.01%.
As of December 22, 2024, the stock is trading at EUR 12.95 with a total of 31,460 shares traded.
Over the past week, the price has changed by -0.37%, over one month by +21.72%, over three months by +7.60% and over the past year by -24.01%.
Is Cegedim S.A. a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Cegedim S.A. is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.75 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CGM as of December 2024 is 10.60. This means that CGM is currently overvalued and has a potential downside of -18.15%.
Neither. Based on ValueRay Fundamental Analyses, Cegedim S.A. is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.75 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CGM as of December 2024 is 10.60. This means that CGM is currently overvalued and has a potential downside of -18.15%.
Is CGM a buy, sell or hold?
Cegedim S.A. has no consensus analysts rating.
Cegedim S.A. has no consensus analysts rating.
What are the forecast for CGM stock price target?
According to ValueRays Forecast Model, CGM Cegedim S.A. will be worth about 11.6 in December 2025. The stock is currently trading at 12.95. This means that the stock has a potential downside of -10.19%.
According to ValueRays Forecast Model, CGM Cegedim S.A. will be worth about 11.6 in December 2025. The stock is currently trading at 12.95. This means that the stock has a potential downside of -10.19%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 16 | 23.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 11.6 | -10.2% |